An in Vivo CT Imaging Study of GMA-Tulip, I-gel, and LMA Supreme (GLAM-II)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorZhejiang Cancer Hospital

About this trial

Laryngeal masks are core devices for supraglottic airway management, and the accuracy of their anatomical position directly impacts ventilation safety and the incidence of complications. Despite their wide clinical application, gaps remain in understanding their in vivo anatomical characteristics. This study aims to evaluate the in vivo anatomical features (e.g., insertion depth, anatomical alignment, tissue compression) of three laryngeal masks (LMA Supreme, I-gel, GMA-Tulip) using CT scanning in anesthetized patients undergoing CT interventional therapy, providing anatomical evidence for optimized laryngeal mask selection and complication prevention.

Eligibility criteria

Qualifiers

Aged 18-75 years, scheduled for CT interventional therapy;

Aged 18-75 years, scheduled for CT interventional therapy;

Body Mass Index (BMI) <30 kg/m²;

Good communication and cooperation, with voluntary signing of the informed consent form.

Disqualifiers

Presence of head/neck or airway anatomical abnormalities (e.g., laryngeal cartilage malformation, Grade III tonsillar hypertrophy, tongue hypertrophy, cervical spine malformation) that may affect laryngeal mask insertion or CT imaging evaluation;

Current participation in other clinical studies.

Trial design

Treatments tested in this trial

  • GMA-Tulip
  • I-gel
  • LMA-Supreme insertion

Treatment groups

9 Participants
are divided into 3 treatment groups

Sponsors and collaborators